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Summary
Energy metabolic system dysfunction (EMSD) is the main cause of 
type 2 diabetes (T2D). The EMSD can be caused by different triggers; 
1- The defect of the gene (s) involved in EMS such as adiponectin,
leptin, and leptin receptor, 2- A disruption in the homeostatic balance
between the gene/protein (s) involved in the protection and break
down of lipid droplets (LDs) within adipocytes in adipose tissue (AT),
3- Gene-environment interaction induced EMSD (e.g. diet can alter
the gene behaviour) and 4- The EMS functionality decreases as people
age. Since there is a high structural and lipid composition similarity
between LDs and plasma lipoproteins and in particular very low-
density lipoprotein (VLDL) particles, it is very important to explain
the link between these two particles that play an important role in the
development of EMSD. All metabolic diseases such as obesity, T2D, IR, 
and cardiovascular metabolic disorders increase with the age because
of the reduction of metabolic function efficiency. The discovery of the
components responsible for premature aging or healthy aging will
provide us with the possibilities to correct premature aging or extend
healthy aging. In this regard, it is essential to apply Systems Biology
combined with the correct question and right study design.
Description
Energy Metabolic System Dysfunction (EMSD) is the main cause 
of type 2 diabetes (T2D). The EMSD can be caused by different triggers; 
1- The defect of the gene (s) involved in EMS such as adiponectin,
leptin, and leptin receptor, 2- A disruption in the homeostatic balance
between the gene/protein(s) involved in the protection and break down 
of lipid droplets (LDs) within adipocytes in adipose tissue (AT), 3-
Gene-environment interaction induced EMSD (e.g. diet can alter the
gene behaviour) and 4- The EMS functionality decreases as people age
[1-4]. Since there is a high structural and lipid composition similarity
between LDs and plasma lipoproteins and in particular very low-
density lipoprotein (VLDL) particles, it is very important to explain
the link between these two particles that play an important role in the
development of EMSD. Both particles are built up of a hydrophobic
core containing lipids and in particular triglycerides (TGs) surrounded 
by a hydrophilic phospholipids monolayer membrane [1-4]. VLDL is
the largest carrier of TGs in plasma and known as TG-enriched VLDL
particles (VLDL-TG). Also, VLDL is the major supplier of Free Fatty
Acids (FFAs) from circulation to adipocytes, which is meant to store
energy as inactive fuel in the form of TGs in LDs. Moreover, VLDL
ensures active energy for skeletal muscles and other tissues via delivery 
of circulated FFAs mediated by fatty acids transporters [1-5]. On the
one hand, an overload of VLDL with TGs (e.g. the diet with high content 
of carbohydrates) leads to large VLDL particles [6], which in turn more 
FFAs are available for the transport to adipocytes and ultimately storage 
in LDs as TGs. Since high carbohydrates diet also increases the risk for
Cardiovascular Diseases (CVDs), Insulin Resistance (IR) and Type 2
Diabetes (T2D), Cherkas et al. and other investigators suggested the
measurement of pooled glycogen (the stored form of glucose) as both
diagnostic marker and follow up therapy of these disease [7-9]. On the
other hand, an overload of LDs with TGs results in the accumulation
of FFAs in the intracellular space of adipocytes, which FFAs can
be transported back to the circulation with severe cardiovascular 
metabolic diseases as consequence. However, the mechanism behind 
the transport of FFAs from adipocytes to the circulation is unknown 
and remained to be investigated. One possible assumption can be 
the penetration of cell membrane via a slowly diffusion process of 
FFAs with plasma membrane mediated by very high hydrophobicity 
character of too much accumulated FFAs in adipocytes. The major 
differences between VLDL particles and LDs are related to their protein 
contents. VLDL contains proteins such as apolipoprotein B, (APOB), 
APOA1, APOA2, APOA-IV, APOA-V, APOC-I, APOC-II, APOC-
III, and APOE, while LDs contains perilipin (PLIN), adipophilin, 
tail-interacting protein of 47 kDa (TIP47), fatty acid binding protein 
4 (FASP4), Hormone Sensitive Lipase (HSL), Adipose Triglyceride 
Lipase (ATGL), S3-12 and OXPAT. LDs-associated proteins divided 
in two groups; one protects and other one tries to degrade LDs. Thus, 
a correct function of these two groups of proteins and a homeostatic 
balance between FFAs delivery and storage of energy in LDs ensures 
the stability and functionality of LDs [1-5,10-14] 
One of the major consequences of EMSD is obesity, which is 
mainly caused by the hypertrophy of LDs in adipocytes, resulting 
in obese adipocytes. Of note, the overnutrition and lack of physical 
activity is largely responsible for the overload of energy in the form of 
TGs in LDs within adipocytes and hypertrophic LDs as consequences. 
Importantly, obesity promotes a chronic inflammatory state, which 
in turn it is implicated in pathophysiological states such as Insulin 
Resistance (IR), T2D, cardiovascular diseases (CVDs) and stroke [1-
5,7-17]. As the prevalence of obesity increases, the risk of developing 
obesity-induced diseases increases too. These obese adipocytes, in turn, 
lead to the inactivation of mitochondria. Importantly, approximately 
80-85% of intracellular space of these obese adipocytes is occupied
by one or two huge LDs. Based on this phenomenon, it is possible to
hypothesize that LDs are the main energy supplier of adipocytes and
not mitochondria. In this regard, the Long Chain Fatty Acids (LCFAs)
are accumulated in adipocytes and cannot be degraded into the Short
Chain Fatty Acids (SCFAs), which mitochondria uses as fuel for
β-oxidation to produce energy (Adenosine triphosphate; ATP). Thus,
these obese adipocytes appeared to inactivate mitochondria. Another
possibility is that the hypertrophic LDs decrease the number of mature 
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In such states, it may be fair to use the term “LDs are the nuclear power 
of the adipocytes”. All metabolic diseases such as obesity, T2D, IR, and 
cardiovascular metabolic disorders increase with the age because the 
metabolic function efficiency reduce with the age.
In general, the aging can be defined simply as “functionality 
reduction of biological process”. Thus, all above mentioned states could 
be just referred to aging or aging-related events. Of note, it is wise to 
discriminate between early or premature aging and normal or healthy 
aging. The both mentioned types of aging are individual-dependent 
[7-17]. The discovery of the components responsible for premature 
aging or healthy aging will provide us with the possibilities to correct 
premature aging or extend healthy aging. In this regard, it is essential 
to apply Systems Biology combined with the correct question and right 
study design. 
Systems Biology will become part of both the biologist’s as well as 
clinician’s toolbox. In a scientifically context, Systems Biology can be 
referred as “the use of a combination of all techniques and knowledge 
(or develop novel ones) to find answer to any biological questions”. 
Importantly, Systems Biology is not a computational and mathematical 
modelling of biological systems, which is wrongly used by many 
scientists. This might be due to the use of bioinformatics instead of 
biological software-omics. In fact, computational and mathematical 
modelling is used to develop software and program to collect data 
from biomedical databases (bioinformatica) derived from scientific 
publications and bring them to the scientists. It must be pointed out 
that bioinformatics is also a component of Systems Biology. However, 
computational and mathematical modelling has to be considered as one 
of the tools in the Systems Biology the same as genomics, proteomics 
and other omics or classical techniques. Since all biomedical databases 
are built up based on scientific publications, bio-software uses well 
these databases as source information, but these softwares cannot 
correct these databases (Figure 1). 
Why is Systems Biology right choice of strategy to study the 
age-related diseases? – Still we poorly understand the fundamental 
mechanisms that mediate the biological and, in turn, pathological 
changes in the age-related diseases such as obesity and its related diseases 
such as T2D, cancer, neurodegenerative diseases (e.g. Alzheimer). 
Obesity, T2D, CVD incidences show a sharp increase in people over the 
age of 50-60. Also, obesity increases cardiovascular disease events via 
the development of T2D, disruption of plasma lipoprotein regulation, 
hyper- or hypo-activity of coagulation/fibrinolysis components, and/
or a mixture of energy metabolism disorders-associated diseases. The 
molecular basis of these age-related events is still poorly understood 
and represents one of the most important questions in the field. This 
indicates that an innovative strategy is essential to prevent, or delay 
age-related diseases or extend healthy aging. Systems Biology (an 
integrated omics approach combined with conventional technology) is 
right approach to find new answers here and to elucidate the biological 
components and participants of aging process and their effects on the 
age-related diseases such as diabetes, cancer and neurodegenerative 
Figure 1: Systems Biology in the “service” of age-related diseases such as obesity, Type 2 diabetes (T2D), cancer, cardiovascular diseases, and any other diseases.
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diseases. Of note, ‘free radical theory of aging’ cannot be missed 
in biological mechanism of ageing. Additionally, the link between 
mitochondria and LDs and their role in generation of free radicals in 
human adipocytes cannot be ignored with respect to obesity and its 
afflictions such as T2D and IR. As an example, Systems Biology can be 
applied to study “Healthy and sick” stem cells: the generation of induced 
pluripotent stem cells (IPSCs) derived from type 1 diabetes (T1D) and 
T2D patients helps us to gain more knowledge about proteome, genome 
and the aetiology of the diabetic disease. Although I confess that wide 
range of knowledge and instruments are necessary for Systems Biology 
approach and that cannot be ignored, the Systems Biology remained 
to be the right choice to study the age-related diseases. Also, Systems 
Biology of human preadipocytes-adipocytes helps us to understand the 
aetiology of obesity and diabetes and to develop novel approaches to 
predict, prevent and treat these metabolic diseases. At last but not least, 
Systems Biology will provide us with clues for developing personalised 
medicine for patients suffering of age-related diseases. 
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